NASDAQ : JUNS
Jupiter Neurosciences, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.37 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.12M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Jupiter Neurosciences, Inc. (JUNS) reported revenue of 64.69K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 64.69K | 21.80K | 233.28K | 638.04K | ||
| Cost of Revenue | 1.88M | 2.09M | 492.66K | 954.79K | 942.81K | 1.45M |
| Gross Profit | -1.82M | -2.07M | -492.66K | -954.79K | -709.52K | -809.65K |
| Selling, General & Admin | 7.99M | 6.84M | 2.60M | 2.92M | 2.72M | 3.10M |
| Operating Expenses | 7.99M | 6.84M | 2.60M | 2.92M | 2.72M | 3.10M |
| Operating Income | -9.81M | -8.91M | -3.09M | -3.87M | -3.43M | -3.91M |
| Interest Expense | -272.92K | -66.02K | -248.37K | -218.71K | -740.85K | -113.99K |
| Interest & Investment Income | 5.06K | 5.56K | 482.00 | 617.00 | 132.00 | |
| Other Non Operating Income (Expenses) | 47.91K | 47.91K | 36.74K | 193.25K | 262.51K | -93.35K |
| EBT Excluding Unusual Items | -10.03M | -8.93M | -3.30M | -3.90M | -3.91M | -4.11M |
| Other Unusual Items | 832.31K | 281.93K | 857.72K | -887.95K | -1.05M | -85.95K |
| Pretax Income | -9.20M | -8.64M | -2.44M | -4.78M | -4.96M | -4.20M |
| Net Income | -9.20M | -8.64M | -2.44M | -4.78M | -4.96M | -4.20M |
| Net Income to Common | -9.20M | -8.64M | -2.44M | -4.78M | -4.96M | -4.20M |
| Shares Outstanding (Basic) | 496.12K | 461.71K | 383.77K | 352.07K | 339.33K | 318.04K |
| Shares Outstanding (Diluted) | 496.12K | 461.71K | 383.77K | 352.07K | 339.33K | 318.04K |
| EPS (Basic) | -18.54 | -18.72 | -6.36 | -13.59 | -14.61 | -13.21 |
| EPS (Diluted) | -18.57 | -18.75 | -6.36 | -13.59 | -14.61 | -13.21 |
| Gross Margin | -126.90% | |||||
| Operating Margin | -15,166.68% | -40,873.19% | -1,471.38% | -612.36% | ||
| Profit Margin | -14,220.12% | -39,662.77% | -2,125.15% | -658.31% | ||
| EBIT | -9.81M | -8.91M | -3.09M | -3.87M | -3.43M | -3.91M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.52M | 3.79M | 3.77M | 28.48K | 64.43K | 330.60K |
| Cash & Short-Term Investments | 1.52M | 3.79M | 3.77M | 28.48K | 64.43K | 330.60K |
| Accounts Receivable | 10.24K | 2.64K | ||||
| Receivables | 10.24K | 2.64K | ||||
| Inventory | 135.29K | 159.79K | ||||
| Prepaid Expenses | 766.67K | 766.67K | 766.67K | 261.00 | ||
| Other Current Assets | 114.73K | 106.54K | 114.09K | 5.23K | 124.07K | |
| Total Current Assets | 2.55M | 4.82M | 4.65M | 28.74K | 69.66K | 454.67K |
| Property, Plant & Equipment | 219.86K | 23.21K | 69.64K | 116.07K | 162.50K | 208.93K |
| Other Long-Term Assets | 949.93K | 715.84K | 1.48M | 3.78K | 3.78K | 3.78K |
| Total Assets | 3.72M | 5.56M | 6.20M | 148.59K | 235.94K | 667.38K |
| Accounts Payable | 360.23K | 131.13K | 278.68K | 189.50K | 187.03K | 256.89K |
| Accrued Expenses | 1.95M | 1.90M | 1.53M | 1.97M | 4.58M | 4.59M |
| Short-Term Debt | 1.53M | 5.30M | 146.43K | 2.02M | 1.73M | 440.61K |
| Current Portion of Leases | 15.54K | 21.25K | 50.08K | 48.21K | 46.40K | 46.19K |
| Current Unearned Revenue | 859.00 | 735.00 | ||||
| Other Current Liabilities | 28.95K | 40.35K | 2.54K | 1.54M | 710.60K | 351.00K |
| Total Current Liabilities | 3.88M | 7.40M | 2.01M | 5.77M | 7.26M | 5.68M |
| Long-Term Debt | 106.71K | |||||
| Long-Term Leases | 205.07K | 21.25K | 71.33K | 119.54K | 164.40K | |
| Total Liabilities | 4.08M | 7.40M | 2.03M | 5.95M | 7.38M | 5.85M |
| Common Stock | 66.00 | 3.44K | 3.31K | 2.65K | 2.64K | 653.00 |
| Additional Paid-In Capital | 38.64M | 32.83M | 30.19M | 17.78M | 11.65M | 8.66M |
| Retained Earnings | -39.00M | -34.67M | -26.02M | -23.58M | -18.80M | -13.84M |
| Shareholders' Equity | -365.97K | -1.83M | 4.17M | -5.80M | -7.14M | -5.18M |
| Total Liabilities & Equity | 3.72M | 5.56M | 6.20M | 148.59K | 235.94K | 667.38K |
| Total Debt | 1.75M | 5.32M | 217.76K | 2.25M | 1.90M | 651.20K |
| Net Cash (Debt) | -227.20K | -1.53M | 3.55M | -2.22M | -1.83M | -320.60K |
| Net Cash Per Share | -0.46 | -3.31 | 9.25 | -6.31 | -5.40 | -1.01 |
| Filing Date Shares Outstanding | 770.08K | 483.75K | 441.38K | 353.69K | 339.33K | 326.91K |
| Total Common Shares Outstanding | 664.67K | 459.29K | 441.38K | 353.69K | 339.33K | 326.91K |
| Working Capital | -1.33M | -2.57M | 2.64M | -5.74M | -7.19M | -5.23M |
| Book Value Per Share | -0.55 | -3.99 | 9.45 | -16.40 | -21.05 | -15.84 |
| Tangible Book Value | -365.97K | -1.83M | 4.17M | -5.80M | -7.14M | -5.18M |
| Tangible Book Value Per Share | -0.55 | -3.99 | 9.45 | -16.40 | -21.05 | -15.84 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -9.20M | -8.64M | -2.44M | -4.78M | -4.96M | -4.20M |
| Other Amortization | 766.67K | 766.67K | 97.90K | 16.71K | 558.03K | 77.13K |
| Stock-Based Compensation | 2.46M | 2.42M | 1.84M | 1.20M | 817.25K | 1.43M |
| Other Operating Activities | -473.69K | -59.41K | -844.47K | 739.20K | 784.90K | 179.30K |
| Change in Accounts Receivable | -10.24K | -2.64K | 126.23K | |||
| Change in Inventory | -135.29K | -159.79K | ||||
| Change in Accounts Payable | 344.28K | 242.16K | -149.53K | 164.88K | -56.28K | -155.26K |
| Change in Unearned Revenue | 859.00 | 735.00 | ||||
| Change in Other Net Operating Assets | -1.00M | 24.92K | -2.42M | 2.18M | 1.61M | 810.31K |
| Operating Cash Flow | -7.25M | -5.41M | -3.91M | -480.95K | -1.25M | -1.74M |
| Short-Term Debt Issued | 5.58M | 138.50K | 390.00K | 982.33K | 527.65K | |
| Total Debt Issued | 5.58M | 5.58M | 138.50K | 390.00K | 982.33K | 527.65K |
| Short-Term Debt Repaid | -146.43K | -2.36M | ||||
| Total Debt Repaid | -552.38K | -146.43K | -2.36M | |||
| Net Debt Issued (Repaid) | 5.03M | 5.43M | -2.22M | 390.00K | 982.33K | 527.65K |
| Issuance of Common Stock | 1.87M | 150.00K | 55.00K | 1.33M | ||
| Other Financing Activities | 9.73M | |||||
| Financing Cash Flow | 6.89M | 5.43M | 7.65M | 445.00K | 982.33K | 1.86M |
| Net Cash Flow | -356.37K | 19.83K | 3.74M | -35.95K | -266.17K | 122.60K |
| Levered Free Cash Flow | -3.26M | -2.31M | -2.92M | -3.12M | -826.16K | 250.69K |
| Unlevered Free Cash Flow | -3.09M | -2.27M | -2.81M | -3.00M | -921.16K | 244.80K |
| Cash Interest Paid | 125.39K | 38.43K | 147.78K | 28.13K | 81.50K | 1.06K |
| Change in Working Capital | -803.61K | 105.39K | -2.57M | 2.35M | 1.55M | 781.29K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.70M | 35.11M | 354.21M | |||
| Enterprise Value | 2.93M | 34.57M | 356.58M | |||
| Last Close Price | 2.05 | 76.50 | 802.50 | |||
| PS Ratio | 41.78 | 1,611.07 | ||||
| PB Ratio | -19.17 | 84.90 | ||||
| P/TBV Ratio | 84.90 | |||||
| EV/Sales Ratio | 45.29 | 1,586.14 | ||||
| Debt / Equity Ratio | -4.78 | -2.90 | 0.05 | -0.39 | -0.27 | -0.13 |
| Net Debt / Equity Ratio | -0.62 | -0.83 | -0.85 | -0.38 | -0.26 | -0.06 |
| Asset Turnover | 0.02 | 0.00 | 0.52 | 1.05 | ||
| Quick Ratio | 0.40 | 0.51 | 1.88 | 0.01 | 0.01 | 0.06 |
| Current Ratio | 0.66 | 0.65 | 2.31 | 0.01 | 0.01 | 0.08 |
| Return on Equity (ROE) | -1,888.70% | -738.83% | ||||
| Return on Assets (ROA) | -159.56% | -94.64% | -60.84% | -1,258.26% | -474.97% | -401.18% |
| Return on Capital Employed (ROCE) | 6,098.10% | 486.30% | -73.70% | 68.80% | 48.90% | 77.90% |
| Earnings Yield | -905.73% | -24.62% | -0.69% | |||
| Buyback Yield / Dilution | -16.80% | -20.31% | -9.01% | -3.75% | -6.69% | -9.51% |